| Dr Malathi Rao, DO | |
|
25 N Winfield Rd, Winfield, IL 60190-1295 | |
| (630) 933-4056 | |
| (630) 933-4057 |
| Full Name | Dr Malathi Rao |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 16 Years |
| Location | 25 N Winfield Rd, Winfield, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265694525 | NPI | - | NPPES |
| 206147 | Other | IL | MEDICARE PTAN (GROUP) |
| F400166053 | Other | IL | MEDICARE PTAN (INDIVIDUAL) |
| 1265694525 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 5101017829 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush University Medical Center | Chicago, IL | Hospital |
| Rush Oak Park Hospital | Oak park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus's impact on their immune system is shown to be small. The nonprofit International Antiviral Society-USA cited new evidence that untreated infection with the human immunodeficiency virus that causes AIDS can also lead to a range of other conditions, including cardiovascular disease and kidney disease.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
The Phenome Center developed out of the Olympic drug testing facility, and we've adapted it so that we use NMR spectrometry, which we have three spectrometers, and mass spectrometry, to take blood and urine from hundreds and thousands of people and profile them to get a biochemical fingerprint of every person.
RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the first published data on the power of radio frequency technology to identify retained surgical items in all patient types.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.
› Verified 5 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus's impact on their immune system is shown to be small. The nonprofit International Antiviral Society-USA cited new evidence that untreated infection with the human immunodeficiency virus that causes AIDS can also lead to a range of other conditions, including cardiovascular disease and kidney disease.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
The Phenome Center developed out of the Olympic drug testing facility, and we've adapted it so that we use NMR spectrometry, which we have three spectrometers, and mass spectrometry, to take blood and urine from hundreds and thousands of people and profile them to get a biochemical fingerprint of every person.
RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the first published data on the power of radio frequency technology to identify retained surgical items in all patient types.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.
› Verified 5 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus's impact on their immune system is shown to be small. The nonprofit International Antiviral Society-USA cited new evidence that untreated infection with the human immunodeficiency virus that causes AIDS can also lead to a range of other conditions, including cardiovascular disease and kidney disease.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
The Phenome Center developed out of the Olympic drug testing facility, and we've adapted it so that we use NMR spectrometry, which we have three spectrometers, and mass spectrometry, to take blood and urine from hundreds and thousands of people and profile them to get a biochemical fingerprint of every person.
RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the first published data on the power of radio frequency technology to identify retained surgical items in all patient types.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.
› Verified 5 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700872355 PECOS PAC ID: 6709774987 Enrollment ID: O20040309000660 |
News Archive
An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus's impact on their immune system is shown to be small. The nonprofit International Antiviral Society-USA cited new evidence that untreated infection with the human immunodeficiency virus that causes AIDS can also lead to a range of other conditions, including cardiovascular disease and kidney disease.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
The Phenome Center developed out of the Olympic drug testing facility, and we've adapted it so that we use NMR spectrometry, which we have three spectrometers, and mass spectrometry, to take blood and urine from hundreds and thousands of people and profile them to get a biochemical fingerprint of every person.
RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the first published data on the power of radio frequency technology to identify retained surgical items in all patient types.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Malathi Rao, DO 25 N Winfield Rd, Winfield, IL 60190-1295 Ph: (630) 933-4056 | Dr Malathi Rao, DO 25 N Winfield Rd, Winfield, IL 60190-1295 Ph: (630) 933-4056 |
News Archive
An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus's impact on their immune system is shown to be small. The nonprofit International Antiviral Society-USA cited new evidence that untreated infection with the human immunodeficiency virus that causes AIDS can also lead to a range of other conditions, including cardiovascular disease and kidney disease.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it has signed an agreement with U.K.-based ProStrakan Group plc (LSE: PSK) for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
The Phenome Center developed out of the Olympic drug testing facility, and we've adapted it so that we use NMR spectrometry, which we have three spectrometers, and mass spectrometry, to take blood and urine from hundreds and thousands of people and profile them to get a biochemical fingerprint of every person.
RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the first published data on the power of radio frequency technology to identify retained surgical items in all patient types.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has filed an IDE with the United States Food and Drug Administration to begin clinical trials for the purpose of obtaining Pre-Market Approval to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.
› Verified 5 days ago
Saima Sabah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 27w350 Highlake Road, Winfield, IL 60190 Phone: 630-933-4607 Fax: 630-933-1933 | |
Zoran Milan Grujic, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-4056 Fax: 630-933-4057 | |
Dr. Danesh A Alam, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 27w350 High Lake Rd Ste 208, Winfield, IL 60190 Phone: 630-933-6767 Fax: 708-686-0010 | |
Dr. Sittanur Shoush, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 25 N. Winfield Rd Ste 401, Winfield, IL 60190 Phone: 630-933-4200 Fax: 630-933-4210 | |
Martin Greenwald, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd Ste 410, Winfield, IL 60190 Phone: 630-933-4200 Fax: 630-933-4210 | |
Dr. Jamie Jill Pacis, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-6631 Fax: 630-933-4936 | |
Tracy Binius, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 25 N Winfield Rd, Winfield, IL 60190 Phone: 630-933-4056 Fax: 630-933-4057 |